In reports from the United States and Italy, over 80% of VHL patients develop CNS HGBs during their lifetime, and more than 90% of patients with VHL-related HGBs develop multiple CNS HGBs [15, 16]. The gene discussed is VHL; the disease is Hemoglobin S Measurement.